Lv4
430 积分 2026-05-07 加入
Comparative Efficacy, Tolerability, and Acceptability of Donanemab, Lecanemab, Aducanumab, Melatonin, and Aerobic Exercise for a Short Time on Cognitive Function in Mild Cognitive Impairment and Mild Alzheimer’s Disease: A Systematic Review and Network Meta-Analysis
2小时前
待确认
Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease
2小时前
已完结
Comparative efficacy, tolerability and acceptability of donanemab, lecanemab, aducanumab and lithium on cognitive function in mild cognitive impairment and Alzheimer's disease: A systematic review and network meta-analysis
6小时前
已完结
Lecanemab in Early Alzheimer’s Disease
6小时前
已完结
皖公网安备34019202002308
